CDX-1127 (Varlilumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CDX-1127 (Varlilumab), covering 2025-05-23 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer [Phase 2]